Selected Cases Steering Committee

Selected Cases Steering Committee

2019 24-27 October 2019 Regnum Carya Convention Center, Antalya - Turkey SELECTED CASES www.endobridge.org STEERING COMMITTEE E. Dale Abel President, ES Dolores Shoback Secretary-Treasurer, ES Andrea Giustina President, ESE Aart J Van Der Lely Immediate Past President, ESE Jens Bollerslev Immediate Past Chair, Education Committee, ESE Camilla Schalin-Jäntti Chair, Education Committee, ESE Fusun Saygili President, SEMT Sadi Gundogdu Past President, SEMT Bulent O. Yildiz Founder & President, EndoBridge® Dilek Yazici Scientific Secreteriat, EndoBridge® Ozlem Celik Scientific Secreteriat, EndoBridge® 2 24 - 27 October, 2019 Antalya - Turkey SCIENTIFICSCIENTIFIC PROGRAMME PROGRAM Friday, 25 October 2019 08.40-09.00 Welcome and Introduction to EndoBridge 2019 MAIN HALL 09.00-11.00 Chairs: Ahmet Sadi Gündoğdu, Füsun Saygılı 09.00-09.30 Modern ways to visualise pituitary tumors - Mark Gurnell 09.30-10.00 What is new in the diagnosis and management of acromegaly Sebastian Neggers 10.00-10.30 Treatment of Cushing disease when surgery fails: Individualized case- based approach - Misa Pfeifer 10.30-11.00 Radiotherapy for pituitary tumors - Michael Brada 11.00-11.20 Coffee Break 11.20-12.50 Interactive Case Discussion Sessions HALL A Pituitary - AJ Van Der Lely, Monica Marazuela HALL B Adrenal - Gary Hammer, Özlem Turhan İyidir HALL C Neuroendocrine tumors - Beata Kos - Kudla, Gregory Kaltsas HALL D Male Reproductive Endocrinology - Dimitrios Goulis, Pınar Kadıoğlu 12.50-14.00 Lunch 14.00-15.30 Interactive Case Discussion Sessions HALL A Pituitary - Misa Pfeifer, Sebastian Neggers HALL B Adrenal - Eystein Husebye, Banu Şarer Yürekli HALL C Neuroendocrine tumors - Beata Kos - Kudla, Gregory Kaltsas HALL D Female Reproductive Endocrinology - Djuro Macut, Alessandra Gambineri 15.30-15.50 Coffee Break 15:50-17:50 Chairs: Gary Hammer, İlhan Tarkun 15.50-16.20 Over or undertreatment of adrenal insufficiency: current and emerging aspects - Eystein Husebye 16.20-16.50 Differential diagnosis, investigation and therapy of bilateral adrenal incidentalomas - Gary Hammer 16.50-17.20 Testosterone therapy in men with hypogonadism - Dimitrios Goulis 17.20-17.50 Hirsutism: Practical approaches to diagnosis and treatment Alessandra Gambineri 23 24 - 27 October, 2019 Antalya - Turkey SCIENTIFICSCIENTIFIC PROGRAMME PROGRAM Saturday, 26 October 2019 09.00-11.00 Chairs: Monica Marazuela, İnan Anaforoğlu 09:00-09:30 Treatment of hypothyroidism and evaluation of the efficacy of treatment Georg Brabant 09:30-10:00 Risk stratification in thyroid cancer - Ayşe Kubat Üzüm 10:00-10:30 Autoimmune thyroid disease - mechanistic update - Monica Marazuela 10:30-11:00 Immune check - point inhibitors and endocrine dysfunction Frederic Castinetti 11.00-11.20 Coffee Break 11.20-12.50 Interactive Case Discussion Sessions HALL A Diabetes - Kathleen Wyne, Marianne Andersen HALL B Bone / Calcium - Barbara Obermayer - Pietsch, Dilek Gogas Yavuz HALL C Thyroid - Georg Brabant, Mehtap Çakır HALL D Obesity / lipids - Connie Newman, Oğuzhan Deyneli 12.50-14.00 Lunch 14.00-15.30 Interactive Case Discussion Sessions HALL A Diabetes - Priyathama Vellanki, Samuel Dagogo - Jack HALL B Bone / Calcium - Jens Bollerslev, Joy Wu HALL C Thyroid - Özgür Demir, Dilek Yazıcı HALL D Obesity / lipids - Uberto Pagotto, Alper Sönmez 15.30-15.50 Coffee Break 15:50-17:50 Chairs: Okan Bülent Yıldız, Mine Adaş 15.50-16.20 An update on gestational diabetes - Marianne Andersen 16.20-16.50 Prediabetes: Pathophysiology, prevention and management Samuel Dagogo - Jack 16.50-17.20 Inpatient management of hyperglycemia - Priyathama Vellanki 17.20-17.50 SGLT inhibitors and GLP Receptor Agonists: Role in altering natural history of diabetic complications - Kathleen Wyne 4 24 - 27 October, 2019 Antalya - Turkey 3 SCIENTIFIC PROGRAM SCIENTIFIC PROGRAMME Sunday, 27 October 2019 09.00-11.00 Chairs: Connie Newman, Aysen Akalın 09.00-09.30 Microbiome and metabolic dysfunction - Oluf Pedersen 09.30-10.00 Central mechanisms in control of body weight and their implications for obesity treatment - Uberto Pagotto 10.00-10.30 NASH: Is there a treatment? - Stergios Polyzos 10.30-11.00 How low should LDL be according to guidelines? - Connie Newman 11.00-11.20 Coffee Break 11.20-13.20 Chairs: Andrea Giustina, Ayşegül Atmaca 11.20-11.50 Update on hypoparathyroidism - Heide Siggelkow 11.50-12.20 Pituitary Diseases and Bone - Andrea Giustina 12.20-12.50 Osteoporosis in relation to pregnancy and lactation Barbara Obermayer - Pietsch 12.50-13.20 New modalities in osteoporosis - Joy Wu 13.20-13.30 Closing comments and adjourn Accredited by the European Accreditation Council for Continuing Medical Education (EACCME). 5 24 - 27 October, 2019 Antalya - Turkey 4 CORPORATECORPORATE SYMPOSIASYMPOSIA Friday, 25 October 2019 Setting a path for success in type 2 diabetes management 18:00 - 19:00 Tsvetalina Tankova Chair: Bülent Okan Yıldız Saturday, 26 October 2019 Clinical Experience with SOLIQUA: Innovative Fixed 08:00 - 09:00 Dose Combination Basal Insulin and GLP1-RA Samuel Dagogo - Jack 6 24 - 27 October, 2019 Antalya - Turkey 5 SELECTEDSELECTED CASES CASES DATE TIME HALL SESSION TITLE O - 01 / Misleading insulin-like growth factor 1 (IGF- 1) levels in an acromegalic patient with liver cirrhosis O - 02 / An ACTH Dependent Cyclic Cushing’s 25.10 11:20 - 12:50 A Pituitary Syndrome O - 03 / Central Diabetes Insipidus Unmasked After Kidney Transplant: A Case Report O - 04 / An unusual case with adrenocortical carcinoma presented during pregnancy O - 05 / Adrenal incidentaloma: A case of co- 25.10 11:20 - 12:50 B Adrenal secreating pheochromocytoma(PCC) with Mild Autonomous Cortisol Excess(MACE) O - 06 / A case with nasal type extranodal NK\T-cell lymphoma with bilateral adrenal gland involvement Neuroendocrine O - 07 / Multiple metastatic liver insulinoma 25.10 11:20 - 12:50 C presenting 4 years after resection of the primary tumors tumor Male O - 08 / An isolated FSH deficiency case due to 25.10 11:20 - 12:50 D reproductive {FSHß} subunit promoter polymorphism c.-211G>T endocrinology O - 09 / Atypical site of TSH-secreting pituitary adenoma- A diagnostic challange O - 10 / Cushing's Disease Due to a Pituitary Adenoma surrounding a Suprasellar/Sellar 25.10 14:00 - 15:30 A Pituitary Meningioma: Case Report O - 11 / Pituitary Involvement of Lymphoma without Diabetes Insipidus: An atypical Presentation O - 12 / A case of Erdheim-Chester presented by hypophysitis O - 13 / Rare two causes of Cushing’s Syndrome: Pigmented adrenal cortical adenoma and adrenocorticotropic hormon secreting pheochromocytoma 25.10 14:00 - 15:30 B Adrenal O - 14 / Autoimmune Polyendocrine Syndrome Type 1 (APS I); rare case with full blown clinical manifestation O - 15 / Restorating Fertility in A Woman with 21 OH Deficiency CAH at Classic/Non-Classic Boundary Extremely High C-peptide Levels in Neuroendocrine O - 16 / 25.10 14:00 - 15:30 C Hypoglycemic Nondiabetic Patient: HIRATA Disease tumors O - 17 / A patient with an atypic neck mass lesion 7 24 - 27 October, 2019 Antalya - Turkey 6 SELECTEDSELECTED CASES CASES DATE TIME HALL SESSION TITLE O - 18 / Mauriac syndrome: Elevated liver enzymes 26.10 11:20 - 12:50 A Diabetes and type 1 diabetes O - 19 / Denosumab for managing extreme hypercalcemia of metastatic parathyroid carcinoma O - 20 / An unusual case of Familial Hypocalciuric 26.10 11:20 - 12:50 B Bone/Calcium Hypercalcemia Treated with cinacalcet O - 21 / PTH washout in diagnosis of primary hyperparathyroidism due to intrathyroidal parathyroid adenoma O - 22 / Severe hyponatremia following rhabdomyolysis and acute renal failure in a young patient with undiagnosed hypothyroidism O - 23 / A patient with thyroid hormone resistance that has been diagnosed within pregnancy 26.10 11:20 - 12:50 C Thyroid O - 24 / A thyrotoxicosis case related to cemiplimab treatment O - 25 / Coexistence of Langerhans Cell Histiocytosis and Papillary Thyroid Carcinoma Revealed as the Culprit behind the Diagnosis Autoimmune Thyroiditis O - 26 / May bariatric surgery be effective in 26.10 11:20 - 12:50 D Obesity / Lipids glycemic regulation in the patients with maturity- onset diabetes of the young? O - 27 / Nondiabetic obese patient with three 26.10 14:00 - 15:30 A Diabetes different MODY gene mutations: a unique case O - 28 / Idiopathic hypercalciuria as differential diagnosis of normocalcemic primary hyperparathyroidism 26.10 14:00 - 15:30 B Bone/Calcium O - 29 / An Unusual Case of Symptomatic Hypercalcemia from Graves Disease in a young Filipino female O - 30 / Metastatic papillary thyroid cancer without primary focus O - 31 / Medullary Thyroid Carcinoma Detected In Supraclavicular Lymph Node Biopsy In Essential Thrombocytosis Patient: Micro-Medullary Carcinoma 26.10 14:00 - 15:30 C Thyroid of Thyroid with Skip Metastasis O - 32 / Poorly differentiated thyroid cancer presenting with thyrotoxicosis and disseminated bone metastasis O - 33 / Subacute thyroiditis: A rare cause of thyrotoxicosis during pregnancy O - 34 / Mandibular hypoplasia, deafness, progeroid features and lipodystrophy syndrome with POLD1 mutation: a 26.10 14:00 - 15:30 D Obesity / Lipids novel type lipodystrophy mimicking scleroderma O - 35 / Effectiveness of plasmapheresis in severe hypertriglyceridemia induced pancreatitis 7 8 24 - 27 October, 2019 Antalya - Turkey ORAL PRESENTATIONS 9 24 - 27 October, 2019 Antalya - Turkey O-01 Pituitary MISLEADING INSuLIN-LIkE GROwTh FACTOR 1 (IGF-1) LEvELS IN AN ACROMEGALIC PATIENT wITh LIvER CIRRhOSIS NURDAN GÜL, ÖZLEM SOYLUK SELÇUKBİRİCİK, AYŞE KUBAT ÜZÜM, REFİK TANAKOL, FERİHAN

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    124 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us